Smoking cessation

Active Ingredient: Cytisine

Indication for Cytisine

Population group: only adults (18 - 65 years old)
Therapeutic intent: Curative procedure

Smoking cessation and reduction of nicotine cravings in smokers who are willing to stop smoking. The treatment goal of cytisine is the permanent cessation of the nicotine‑containing products use.

For this indication, competent medicine agencies globally authorize below treatments:

9 mg maximum daily dose for days 1–3, followed by a gradual reduction to a maximum daily dose of 3 mg for days 21–25

For:

Dosage regimens

Oral, 1.5 milligrams cytisine, once every 2 hours, 6 doses in total, over the duration of 3 days. Afterwards, oral, 1.5 milligrams cytisine, once every 2.5 hours, 5 doses in total, over the duration of 9 days. Afterwards, oral, 1.5 milligrams cytisine, once every 3 hours, 4 doses in total, over the duration of 4 days. Afterwards, oral, 1.5 milligrams cytisine, once every 5 hours, 3 doses in total, over the duration of 4 days. Afterwards, oral, 1.5 milligrams cytisine, 1 to 2 times daily, over the duration of 5 days.

Detailed description

The duration of therapy is 25 days.

Cytisine should be taken according to the following schedule:

Days of treatmentRecommended dosingMaximum daily dose
From the 1st to the 3rd day1.5 mg every 2 hours9 mg
From the 4th to the 12th day1.5 mg every 2.5 hours7.5 mg
From the 13th to the 16th day1.5 mg every 3 hours6 mg
From the 17th to the 20th day1.5 mg every 5 hours4.5 mg
From the 21st to the 25th day1.5-3 mg a dayto 3 mg

Smoking should be stopped no later than on the 5th day of treatment. Smoking should not be continued during treatment as this may aggravate adverse reactions. In case of treatment failure, the treatment should be discontinued and may be resumed after 2 to 3 months.

Special population (renal impairment, hepatic impairment)

There is no clinical experience of cytisine in patients with renal or hepatic impairment, therefore the drug product is not recommended for use in this patient population.

Elderly population

Due to limited clinical experience, cytisine is not recommended for use in elderly patients over 65 years of age.

Active ingredient

Cytisine

Cytisine is a plant alkaloid with a chemical structure similar to nicotine. The use of cytisine allows for a gradual reduction of nicotine dependence by relieving withdrawal symptoms. The action of cytisine is similar to that of nicotine, but in general weaker. Cytisine competes with nicotine for the same receptors and gradually displaces nicotine due to its stronger binding.

Read more about Cytisine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.